119 related articles for article (PubMed ID: 32786185)
1. People with Hepatitis C Who Inject Drugs - Underserved, Not Undeserving.
Dore GJ; Trooskin S
N Engl J Med; 2020 Aug; 383(7):608-611. PubMed ID: 32786185
[No Abstract] [Full Text] [Related]
2. Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.
Kikvidze T; Luhmann N; Avril E; Butsashvili M; Labartkava K; Etienne A; Le Pluart D; Inaridze I; Gamezardashvili A; Kharshiladze D; Bouscaillou J
Int J Drug Policy; 2018 Feb; 52():16-19. PubMed ID: 29227878
[No Abstract] [Full Text] [Related]
3. A Call to Action: HCV Treatment of People Who Inject Drugs in the United States.
Norton BL; Litwin AH
Clin Infect Dis; 2020 May; 70(11):2366-2368. PubMed ID: 31513706
[No Abstract] [Full Text] [Related]
4. Scale-up of hepatitis C treatment in prisons is key to national elimination.
Papaluca T; Hellard ME; Thompson AJV; Lloyd AR
Med J Aust; 2019 May; 210(9):391-393.e1. PubMed ID: 30968417
[No Abstract] [Full Text] [Related]
5. High HIV and HCV and the unmet needs of people who inject drugs in Yerevan, Armenia.
Johnston L; Grigoryan S; Papoyan A; Grigoryan T; Balayan T; Zohrabyan L
Int J Drug Policy; 2014 Jul; 25(4):740-3. PubMed ID: 24612640
[No Abstract] [Full Text] [Related]
6. Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?
Gountas I; Sypsa V; Anagnostou O; Martin N; Vickerman P; Kafetzopoulos E; Hatzakis A
Addiction; 2017 Jul; 112(7):1290-1299. PubMed ID: 28107585
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus Treatment and Persons Who Inject Drugs.
McCance-Katz EF; Valdiserri RO
Ann Intern Med; 2016 Feb; 164(3):203-4. PubMed ID: 26829915
[No Abstract] [Full Text] [Related]
8. Hepatitis C Virus Treatment and Persons Who Inject Drugs.
Grebely J; Dore GJ; Greenwald R; Swan T; Barua S; Taylor LE
Ann Intern Med; 2016 Feb; 164(3):203. PubMed ID: 26829914
[No Abstract] [Full Text] [Related]
9. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
Zanini B; Lanzini A
Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic hepatitis C in active drug users.
Davis GL; Rodrigue JR
N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
[No Abstract] [Full Text] [Related]
11. Treatment for hepatitis C virus infection among current injection drug users in Australia.
Matthews G; Kronborg IJ; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
[TBL] [Abstract][Full Text] [Related]
12. Is the end of chronic hepatitis C virus infection in sight?
McCaughan GW
Med J Aust; 2012 Jun; 196(10):614. PubMed ID: 22676864
[No Abstract] [Full Text] [Related]
13. Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.
Kåberg M; Hammarberg A; Lidman C; Weiland O
Infect Dis (Lond); 2017 Oct; 49(10):728-736. PubMed ID: 28574295
[TBL] [Abstract][Full Text] [Related]
14. Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.
Echevarria D; Gutfraind A; Boodram B; Major M; Del Valle S; Cotler SJ; Dahari H
PLoS One; 2015; 10(8):e0135901. PubMed ID: 26295805
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Mabileau G; Dhersin JS; Yazdanpanah Y
J Viral Hepat; 2018 Oct; 25(10):1197-1207. PubMed ID: 29660211
[TBL] [Abstract][Full Text] [Related]
16. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
[TBL] [Abstract][Full Text] [Related]
17. Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals.
Schütz A; Moser S; Schwanke C; Schubert R; Luhn J; Gutic E; Lang T; Schleicher M; Haltmayer H; Gschwantler M
J Viral Hepat; 2018 Jul; 25(7):870-873. PubMed ID: 29316001
[TBL] [Abstract][Full Text] [Related]
18. It's Not Them, It's Us: Hepatitis C Reinfection Following Successful Treatment Among People Who Inject Drugs.
Barocas JA
Clin Infect Dis; 2021 Apr; 72(8):1401-1403. PubMed ID: 32166311
[No Abstract] [Full Text] [Related]
19. Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era.
Falade-Nwulia O; Sulkowski MS; Merkow A; Latkin C; Mehta SH
J Viral Hepat; 2018 Mar; 25(3):220-227. PubMed ID: 29316030
[TBL] [Abstract][Full Text] [Related]
20. Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era.
Valerio H; McAuley A; Innes H; Palmateer N; Goldberg DJ; Munro A; Taylor A; Hutchinson SJ
Int J Drug Policy; 2018 Feb; 52():115-122. PubMed ID: 29414462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
